Tocilizumab in systemic sclerosis treatment: a case report

INTRODUCTION: In the United States, tocilizumab was approved for the treatment of scleroderma and scleroderma-related interstitial lung disease because it inhibited the decrease in forced expiratory volume, so scleroderma treatment is entering a new era. CASE PRESENTATION: A 44-year-old female patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudsi, Maysoun, Khalayli, Naram, Tarcha, Raghad, Al-Darwish, Lama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473287/
https://www.ncbi.nlm.nih.gov/pubmed/37663690
http://dx.doi.org/10.1097/MS9.0000000000000969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473287/
https://www.ncbi.nlm.nih.gov/pubmed/37663690
http://dx.doi.org/10.1097/MS9.0000000000000969

Ejemplares similares